Surgery for hyperparathyroidism in image-negative patients

Archives of Surgery

Volumn 143, Issue 4, 2008, Pages 335-337

  Chan, Rodney K ^a   Ruan, Daniel T ^a   Gawande, Atul A ^a   Moore Jr , Francis D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADENOMA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; PARATHYROID HYPERPLASIA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; THYMECTOMY; THYROIDECTOMY; TREATMENT INDICATION; ULTRASOUND; ANALYSIS OF VARIANCE; ECHOGRAPHY; PRIMARY HYPERPARATHYROIDISM; PROSPECTIVE STUDY; SCINTISCANNING; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 42449159792     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.143.4.335     Document Type: Article

References (12)

1. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140(5):472-479.
2. Gawande AA, Monchik JM, Abbruzzese TA, Iannuccilli JD, Ibrahim SI, Moore FD Jr. Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch Surg. 2006;141(4):381-384.
3. Sebag F, Hubbard JG, Maweja S, Misso C, Tardivet L, Henry JF. Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery. 2003;134(6):1038-1041.
4. Chan RK, Ibrahim SI, Pil P, Tanasijevic M, Moore FD. Validation of a method to replace frozen section during parathyroid exploration by using the rapid parathyroid hormone assay on parathyroid aspirates. Arch Surg. 2005;140(4):371-373.
5. Moore FD Jr, Mannting F, Tanasijevic M. Intrinsic limitations to unilateral parathyroid exploration. Ann Surg. 1999;230(3):382-391.
6. Rasmussen K, Larsen LP, Arveschoug A, et al. Predictive value of parathyroid scintigraphy in the preoperative evaluation of patients with primary hyperparathyroidism. Scand J Surg. 2006;95(3):199-204.
7. Lo CY, Lang BH, Chan WF, Kung AW, Lam KS. A prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism. Am J Surg. 2007;193(2):155-159.
8. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302(4):189-193.
9. Sugg SL, Krzywda EA, Demeure MJ, Wilson SD. Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Surgery. 2004;136(6):1303-1309.
10. Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg. 2006;30(5):697-704.
11. Goldstein RE, Carter WM II, Fleming M, et al. Unilateral cervical surgical exploration aided by intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and equivocal sestamibi scan results. Arch Surg. 2006;141(6):552-559.
12. Goldstein RE, Billheimer D, Martin WH, Richards K. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg. 2003;237(5):722-731.